2026 Advances in Chronic Graft-Versus-Host Disease: Translating Evidence into Practice

This one-day multidisciplinary Chronic GVHD Conference is designed to advance the understanding and management of adult and pediatric chronic graft-versus-host disease (cGVHD). The activity brings together experts in hematology, transplantation, dermatology, ophthalmology, gynecology, pulmonary, pharmacy, dental, nutrition, and supportive care to review current research, practical management strategies, and emerging innovations in the field.

The program features a keynote address by Stephanie Lee, MD, MPH, on patient-reported outcomes in adult and pediatric cGVHD, followed by expert-led presentations on the biology of chronic GVHD and organ-specific manifestations, including ocular, oral, gynecologic, cutaneous, musculoskeletal, pulmonary, endocrine, and nutritional issues. Additional sessions address oral cancer screening, pediatric and adult pharmacy considerations, AI-driven data mining for clinical insight, new apps for GVHD care, and strategies for building a multidisciplinary GVHD clinic.

Interactive panel discussions throughout the day will highlight real-world approaches to diagnosis, symptom management, and coordinated care across specialties. The activity also includes dedicated sessions on managing adult and pediatric patients with cGVHD, as well as a closing debate on perspectives in combination therapy. 

Participants are invited to attend a networking reception following the accredited sessions. RSVP is encouraged at the time of registration.

This educational activity is intended for clinicians and allied health professionals involved in the care of patients with chronic GVHD and offers a comprehensive, team-based perspective on improving outcomes and shaping the future of cGVHD care.

1. Analyze the underlying biologic and immunopathogenic mechanisms of chronic GVHD and synthesize current evidence on disease progression to inform rational selection and sequencing of newly approved systemic therapies.
2. Apply diagnostic and therapeutic principles of chronic GVHD, demonstrating the ability to distinguish disease activity from damage and develop individualized management strategies across organ systems.
3. Evaluate and integrate available assessment tools, patient-reported outcomes (PROs), and emerging technologies, including digital imaging and data analytics, to enhance diagnosis, monitoring, and response assessment in chronic GVHD.

Registration Fees

• Physicians (MDs, PhDs, DOs): $300

• Advanced Practice Providers: $250

• Residents and Fellows: $100

• Nurses and Other Healthcare Professionals: $150

• Industry Professionals*: $525

• MSK Employees: Complimentary

Registration Discounts: Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our policy on Registration Discounts for more information.

Cancellation Policy: For details on our cancellation terms, please review our Cancellation Policy.

*An industry professional is defined as any individual, irrespective of their provider type (such as MDs, PhDs, APPs, RNs, etc.) that is employed by an ineligible company. Please review our Registration Policy for Industry Professionals for more information.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statements

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 credits/points in the following certification programs:

• Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification Assessment Recognition Program; and

• Lifelong Learning & Self-Assessment MOC points for the American Board of Pediatrics (ABP) Maintenance of Certification program; and

• Accredited CME and Self-Assessment credits for the American Board of Surgery (ABS) Continuous Certification program.

MOC/CC points will be reported to your board within 45 days of course completion.

An application has been submitted for ANCC Nursing contact hours.

Hotels and Other Accommodations

If you are traveling to New York City from out of town, early hotel arrangements are strongly recommended. Memorial Sloan Kettering Cancer Center has arranged preferred rates and amenities at select Manhattan hotels. Click here to view participating hotels and additional details.

Travel and Parking

For information on traveling to MSK, including directions and parking options, click here. Please note that parking validation is not available for course attendees.

Accessibility

If you require any specific accommodations to attend this event in person, please contact [email protected] at least one week in advance.

MSK Course Directors

Andrew Harris, MD
Associate Attending Pediatrician
Bone Marrow Transplant Service 

Alina Markova, MD
Vice Chair, Quality, Department of Medicine
Section Head, General Dermatology and Oncodermatology

Doris M. Ponce, MD, MS
Co-Chair, Center for Hematologic Malignancies Translational Research Council
Director, Graft-Versus-Host Disease Program

Guest Keynote Speaker 

Stephanie Lee, MD, MPH
Professor and Associate Director 
Member, Immunotherapy Integrated Research Center
David and Patricia Giuliani/Oliver Press Endowed Chair in Cancer Research
Fred Hutchinson Cancer Center

Guest Faculty 

Jessica Ciralsky, MD
Associate Professor of Clinical Ophthalmology
Weill Cornell Mediciner

Joe Le Hsu, MD, MPH
Assistant Professor of Medicine (Pulmonary and Critical Care)
Stanford University School of Medicine

Aimee Morrison, MD
Assistant Professor of Clinical Obstetrics and Gynecology
Weill Cornell Medicine

Jackie Mays, DDS, PhD
Lasker Clinical Research Scholar
Oral Immunobiology Unit
National Institute of Dental and Craniofacial Research (NIDCR at NIH)

Ryo Miyakawa, MD
Assistant Professor of Clinical Pediatrics
Weill Cornell Medicine

MSK Faculty 

Stephen Eng, PharmD
Bone Marrow Transplant Clinical Pharmacy Specialist

Cherry Estilo, DMD
Attending Dental Oncologist

Azeez Farooki, MD
Attending Endocrinologist

Katarzyna Ibanez, MD
Associate Attending, Rehabilitation Medicine

Binni Kunvarjee, PharmD
Clinical Pharmacy Specialist

Ivan Maillard, MD, PhD
Laurence Joseph Dineen Chair in Leukemia Research
Head of the Division of Hematologic Malignancies
Attending Physician

Michelle Myers, MS, RDN, CSO, CDN
Clinical Dietitian-Nutritionist

Gagan Raju, MD
Assistant Attending Physician, Bone Marrow Transplant Service

Veronica Rotemberg, MD, PhD
Director, Dermatology Informatics Program
Associate Attending Dermatologist

Grigory Syrkin, MD
Director, Inpatient Cancer Rehabilitation
Associate Attending, Rehabilitation Medicine

SaeHee Kim Yom, DDS
Assistant Attending Dental Oncologist

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.